Hematologic indices as an available tool in the diagnosis of adverse course of COVID-19
- Authors: Podzolkov V.I.1, Volchkova E.V.1, Pokrovskaya A.E.1, Vanina D.D.1, Vargina T.S.1, Hutkina I.D.1, Ashirova G.I.1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 96, No 11 (2024): Инфекционные заболевания
- Pages: 1028-1034
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/275831
- DOI: https://doi.org/10.26442/00403660.2024.11.202996
- ID: 275831
Cite item
Full Text
Abstract
Aim. To study the prognostic significance of hematologic indices: neutrophils/lymphocytes (N/L), platelets/lymphocytes (P/L) and lymphocytes/C-reactive protein (L/CRP) in relation to the complicated course of new coronavirus infection (COVID-19), as well as their correlation with COVID-19 course severity indices and endothelial dysfunction marker sVCAM-1.
Materials and methods. 103 patients with new coronavirus infection (COVID-19) were included in the study. Based on the data of multispiral computed tomography (CT) of the chest organs, all patients were divided into 3 groups: CT group 1 – 30 patients, CT group 2 – 62 patients and CT group 3 – 11 patients.
Results. The values of N/L and P/L were significantly higher in patients of CT group 3 compared to patients of CT group 1 and CT group 2. L/CRP index, on the contrary, significantly decreased with increasing CT-degree of lung lesion. The concentration of endothelial dysfunction marker sVCAM-1 was significantly higher in patients of CT-3 and 2 groups compared to patients of CT-1 group – 272.7 [267.4; 342.6] ng/mL and 212.5 [90.3; 335.6] ng/mL vs 120.0 [75.3; 189.2] ng/mL. Significant correlations of the studied hematologic indices with clinical, laboratory and instrumental characteristics of COVID-19 severity were found. P/L and L/CRP indices were associated with sVCAM-1 concentration in blood (r=0.28 and -0.33 respectively; p<0.05). The values of N/L>2.53 and L/CRP≤0.043 are predictors of the development of cytokine storm in the examined patients.
Conclusion. Hematologic indices N/L, P/L and L/CRP are correlated with clinical, laboratory and instrumental characteristics of COVID-19 severity, presence of endothelial dysfunction (P/L and L/CRP) and allow predicting the development of cytokine storm (N/L and L/CRP).
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Valery I. Podzolkov
Sechenov First Moscow State Medical University (Sechenov University)
Email: pokrovskaya_a_e@staff.sechenov.ru
ORCID iD: 0000-0002-0758-5609
д-р мед. наук, проф., зав. каф. факультетской терапии №2, дир. клиники факультетской терапии №2
Russian Federation, MoscowElena V. Volchkova
Sechenov First Moscow State Medical University (Sechenov University)
Email: pokrovskaya_a_e@staff.sechenov.ru
ORCID iD: 0000-0002-6578-1026
MD, Dr. Sci (Med.), Professor
Russian Federation, MoscowAnna E. Pokrovskaya
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: pokrovskaya_a_e@staff.sechenov.ru
ORCID iD: 0000-0002-8875-9032
канд. мед. наук, доц. каф. факультетской терапии №2
Russian Federation, MoscowDaria D. Vanina
Sechenov First Moscow State Medical University (Sechenov University)
Email: pokrovskaya_a_e@staff.sechenov.ru
ORCID iD: 0000-0003-1959-370X
ассистент каф. факультетской терапии №2
Russian Federation, MoscowTatiana S. Vargina
Sechenov First Moscow State Medical University (Sechenov University)
Email: pokrovskaya_a_e@staff.sechenov.ru
ORCID iD: 0000-0003-3076-4231
доц. каф. факультетской терапии №2
Russian Federation, MoscowInessa D. Hutkina
Sechenov First Moscow State Medical University (Sechenov University)
Email: pokrovskaya_a_e@staff.sechenov.ru
ORCID iD: 0009-0001-8805-1982
студентка Института клинической медицины им. Н.В. Склифосовского
Russian Federation, MoscowGaliya I. Ashirova
Sechenov First Moscow State Medical University (Sechenov University)
Email: pokrovskaya_a_e@staff.sechenov.ru
ORCID iD: 0009-0009-7268-5655
врач-терапевт Университетской клинической больницы №4
Russian Federation, MoscowReferences
- WHO COVID-19 dashboard. Number of COVID-19 cases reported to WHO. Available at: https://covid19.who.int/ Accessed: 06.10.2024.
- Лещенко И.В., Эсаулова Н.А., Глушкова Т.В., и др. Респираторные нарушения при постковидном синдроме. Терапевтический архив. 2023;95(3):203-9 [Leshchenko IV, Esaulova NA, Glushkova TV, et al. Respiratory disorders of post-COVID-19 syndrome. Terapevticheskii arkhiv. (Ter. Arkh.). 2023;95(3):203-9 (in Russian)]. doi: 10.26442/00403660.2023.03.202072
- Подзолков В.И., Тарзиманова А.И., Брагина А.Е., и др. Предикторы возникновения фибрилляции предсердий у больных с коронавирусной инфекцией SARS-CoV-2 (COVID-19). Российский кардиологический журнал. 2022;27(7):5095 [Podzolkov VI, Tarzimanova AI, Bragina AE, et al. Predictors of atrial fibrillation in patients with COVID-19. Russian Journal of Cardiology. 2022;27(7):5095 (in Russian)]. doi: 10.15829/1560-4071-2022-5095
- Подзолков В.И., Брагина А.Е., Тарзиманова А.И., и др. Артериальная гипертензия и неблагоприятное течение COVID-19 среди госпитализированных больных: данные когортного исследования из России. Рациональная Фармакотерапия в Кардиологии. 2023;19(1):4-10 [Podzolkov VI, Bragina AE, Tarzimanova AI, et al. Arterial Hypertension and Severe COVID-19 in Hospitalized Patients: Data from a Cohort Study. Rational Pharmacotherapy in Cardiology. 2023;19(1):4-10 (in Russian)]. doi: 10.20996/1819-6446-2023-01-10
- Подзолков В.И., Покровская А.Е., Ванина Д.Д., и др. sVCAM-1 – как маркер эндотелиальной дисфункции, ассоциированный с тяжелым течением новой коронавирусной инфекции (COVID-19). Рациональная Фармакотерапия в Кардиологии. 2023;19(2):134-42 [Podzolkov VI, Pokrovskaya AE, Vanina DD, et al. sVCAM-1 as a Marker of Endothelial Dysfunction associated with Severe Course of a Novel Coronavirus Infection (COVID-19). Rational Pharmacotherapy in Cardiology. 2023;19(2):134-42 (in Russian)]. doi: 10.20996/1819-6446-2023-03-08
- Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Временные методические рекомендации. Версия 12 (12.09.2022). Режим доступа: https:// static-0.minzdrav.gov.ru/system/attachments/attaches/000/058/075/ original/ВМР_COVID-19_ V12.pdf. Ссылка активна на 27.12.2023 [Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Available at: https:// static-0.minzdrav.gov.ru/system/attachments/attaches/000/058/075/original/ВМР_COVID-19_V12.pdf. Accessed: 27.12.2023 (in Russian)].
- Bhaskar S, Sinha A, Banach M, et al. Cytokine Storm in COVID-19 – Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648. doi: 10.3389/fimmu.2020.01648
- Кузник Б.И., Смоляков Ю.Н., Хавинсон В.Х., и др. Нейтрофилы, лимфоциты и их соотношение как предикторы исходов у больных COVID-19. Патологическая физиология и экспериментальная терапия. 2021;65(4):34-41 [Kuznik BI, Smolyakov YuN, Khavinson VH, et al. Neutrophils, lymphocytes and their ratio as predictors of outcome in patients with COVID-19. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya. 2021;65(4):34-41 (in Russian)]. doi: 10.25557/0031-2991.2021.04.34-41
- Feng X, Li S, Sun Q, et al. Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020;9(7):301. doi: 10.3389/fmed.2020.00301
- Ullah W, Basyal B, Tariq S, et al. Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19. J Clin Med Res. 2020;12(7):415-22. doi: 10.14740/jocmr4227
- Palladino M. Complete blood count alterations in COVID-19 patients: A narrative review. Biochem Med (Zagreb). 2021;31(3):030501. doi: 10.11613/BM.2021.030501
- Станевич О.В., Бакин Е.А., Коршунова А.А., и др. Информативность основных клинико-лабораторных показателей для пациентов с тяжелой формой COVID-19. Терапевтический архив. 2022;94(11):1225-33 [Stanevich OV, Bakin EA, Korshunova AA, et al. Informativeness estimation for the main clinical and laboratory parameters in patients with severe COVID-19. Terapevticheskii arkhiv. (Ter. Arkh.). 2022;94(11):1225-33 (in Russian)]. doi: 10.26442/00403660.2022.11.201941
- Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. HLH Across Speciality Collaboration, UK. Lancet. 395(10229):1033-34. doi: 10.1016/S0140-6736(20)30628-0
- Подзолков В.И., Волчкова Е.В., Тарзиманова А.И., и др. Предикторы тромбоэмболических осложнений у пациентов с тяжелым течением коронавирусной инфекции SARS-CoV-2. Терапевтический архив. 2023;95(11):907-12 [Podzolkov VI, Volchkova EV, Tarzimanova AI, et al. Predictors of thromboembolic complications in patients with severe SARS-CoV-2 coronavirus infection. Terapevticheskii arkhiv (Ter. Arkh.). 2023;95(11):907-12 (in Russian)]. doi: 10.26442/00403660.2023.11.202472
- Qu R, Ling Y, Zhang YH, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020;92(9):1533-41.doi: 10.1002/jmv.25767
- Mousavi SA, Rad S, Rostami T, et al. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology. 2020;25(1):383-8. doi: 10.1080/16078454.2020.1833435
- Sarkar S, Kannan S, Khanna P, et al. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis. J Med Virol. 2022;94(1):211-21. doi: 10.1002/jmv.27297
Supplementary files
